CL2017001212A1 - Composiciones, dispositivos y método para pruebas de sensibilidad de síndrome del intestino irritable - Google Patents

Composiciones, dispositivos y método para pruebas de sensibilidad de síndrome del intestino irritable

Info

Publication number
CL2017001212A1
CL2017001212A1 CL2017001212A CL2017001212A CL2017001212A1 CL 2017001212 A1 CL2017001212 A1 CL 2017001212A1 CL 2017001212 A CL2017001212 A CL 2017001212A CL 2017001212 A CL2017001212 A CL 2017001212A CL 2017001212 A1 CL2017001212 A1 CL 2017001212A1
Authority
CL
Chile
Prior art keywords
compositions
value
average
discriminatory
devices
Prior art date
Application number
CL2017001212A
Other languages
English (en)
Spanish (es)
Inventor
Elisabeth Laderman
Cohen Zackary Irani
Original Assignee
Biomerica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerica Inc filed Critical Biomerica Inc
Publication of CL2017001212A1 publication Critical patent/CL2017001212A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
CL2017001212A 2014-11-14 2017-05-12 Composiciones, dispositivos y método para pruebas de sensibilidad de síndrome del intestino irritable CL2017001212A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462079783P 2014-11-14 2014-11-14

Publications (1)

Publication Number Publication Date
CL2017001212A1 true CL2017001212A1 (es) 2017-11-24

Family

ID=55955180

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017001212A CL2017001212A1 (es) 2014-11-14 2017-05-12 Composiciones, dispositivos y método para pruebas de sensibilidad de síndrome del intestino irritable

Country Status (15)

Country Link
US (4) US10309970B2 (enExample)
EP (2) EP3218716A4 (enExample)
JP (4) JP6681907B2 (enExample)
KR (4) KR102375614B1 (enExample)
CN (4) CN113671173A (enExample)
AU (4) AU2015346097A1 (enExample)
BR (1) BR112017010078A2 (enExample)
CA (2) CA3145879C (enExample)
CL (1) CL2017001212A1 (enExample)
CO (1) CO2017005773A2 (enExample)
HK (2) HK1243178A1 (enExample)
MX (2) MX385004B (enExample)
PE (1) PE20171093A1 (enExample)
SG (2) SG10201912464QA (enExample)
WO (1) WO2016077808A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3145879C (en) 2014-11-14 2025-07-08 Biomerica, Inc. Compositions, devices, and methods of ibs sensitivity testing
KR20180043790A (ko) 2015-07-22 2018-04-30 바이오메리카인코포레이티드 식품 민감도 시험에 근거하여 식품 권고를 제공하기 위한 시스템 및 방법
US20190056408A1 (en) * 2015-09-09 2019-02-21 Biomerica, Inc. Compositions, devices, and methods of osteoarthritis sensitivity testing
CN108700575A (zh) * 2015-12-21 2018-10-23 拜尔梅里科有限公司 偏头痛食物敏感测试的组合物、设备以及方法
EP3394623B1 (en) * 2015-12-21 2024-08-21 Biomerica, Inc. Compositions, devices, and methods of psoriasis food sensitivity testing
AU2017235312A1 (en) * 2016-03-15 2018-10-04 Biomerica, Inc. Compositions, devices, and methods of fibromyalgia sensitivity testing
AU2017257278A1 (en) * 2016-04-26 2018-12-06 Biomerica, Inc. Compositions, devices, and methods of Crohn's Disease sensitivity testing
MX2018013120A (es) * 2016-04-26 2019-03-28 Biomerica Inc Composiciones, dispositivos y metodos de prueba de sensibilidad a la colitis ulcerosa.
EP3468458B1 (en) * 2016-06-13 2024-09-11 Biomerica Inc. Compositions, devices, and methods of gastroesophageal reflux disease sensitivity testing
AU2017293937A1 (en) * 2016-07-08 2019-01-24 Biomerica, Inc. Compositions, devices, and methods of depression sensitivity testing
EP3497447B1 (en) 2016-07-08 2024-09-04 Biomerica, Inc. Compositions, devices, and methods of depression sensitivity testing
CA3085431A1 (en) * 2016-12-15 2018-06-21 Biomerica, Inc. Compositions, devices, and methods of attention deficit disorder/attention deficit hyperactivity disorder (add/adhd) sensitivity testing
EP3913371A1 (en) 2020-05-18 2021-11-24 Neuroimmun GmbH Method and kit for diagnosting irritable bowel syndrome and for its relief through dietary interventions
EP4487123A4 (en) * 2022-03-02 2026-02-25 Abreos Biosciences Inc METHODS AND COMPOSITIONS FOR MEASURING SERUM ANALYTE LEVELS FROM BIOLOGICAL MATRICES

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
CN1161200A (zh) * 1995-11-28 1997-10-08 拜尔公司 持久释放的硝苯啶制剂
WO1999039211A1 (en) 1998-01-30 1999-08-05 Sampson Hugh A Prognostic allergy or inflammation test
US6152887A (en) 1998-02-27 2000-11-28 Blume; Richard Stephen Method and test kit for oral sampling and diagnosis
US20020002270A1 (en) * 1999-06-16 2002-01-03 Raymond P. Zinkowski Purified antigen for alzheimer's disease, and methods of obtaining and using same
US6458550B1 (en) * 2000-01-07 2002-10-01 Rush-Presbyterian-St. Luke's Medical Center Test for ovarian autoimmunity by detecting autoantibodies to CYP17
US6667160B2 (en) 2000-03-15 2003-12-23 Kenneth D. Fine Method for diagnosing immunologic food sensitivity
EP1195606A1 (en) 2000-10-03 2002-04-10 VBC-Genomics Forschungsges.m.b.H. Allergen-microarray assay
US6858398B2 (en) 2001-08-14 2005-02-22 Immunosciences Lab., Inc. Saliva test for detection of food allergy and intolerance
JP4073231B2 (ja) * 2002-03-28 2008-04-09 久光製薬株式会社 シ−ト状貼付剤
US20040091843A1 (en) 2002-11-12 2004-05-13 Albro Todd M. Menu generator, system and methods for generating clinical menus
GB0310522D0 (en) * 2003-05-08 2003-06-11 Yorktest Lab Ltd Assay panel
US20050137987A1 (en) 2003-12-22 2005-06-23 Robert May Customer age verification
US8309318B2 (en) 2004-02-10 2012-11-13 Brendan Bioscience, Llc Detection of antigen specific immunocomplexes
US20050255533A1 (en) * 2004-02-10 2005-11-17 Brendan Bioscience, Llc Comprehensive food allergy test
US7353080B2 (en) 2004-02-19 2008-04-01 Walker Digital, Llc Products and processes for controlling access to vending machine products
US7601509B2 (en) * 2004-07-15 2009-10-13 Power Laura W Biotype diets system: predicting food allergies by blood type
US7756604B1 (en) 2005-03-09 2010-07-13 Davis Daniel W Product control system
US20070117217A1 (en) 2005-06-16 2007-05-24 The Regents Of The University Of California Large scale parallel immuno-based allergy test and device for evanescent field excitation of fluorescence
US20080073430A1 (en) 2006-09-22 2008-03-27 Sickenius Louis S Sense and Respond Purchase Restriction Management System
US8709413B2 (en) 2006-12-13 2014-04-29 Michael R. Simon Treatment of celiac disease with IgA
US20090208984A1 (en) * 2007-03-30 2009-08-20 Scott David L DETECTION OF FOOD SPECIFIC HUMAN IgG4 ANTIBODIES
WO2008149364A2 (en) * 2007-06-07 2008-12-11 Sarah Brenner Methods for diagnosing hypersensitivity reactions
US20100227340A1 (en) * 2007-09-10 2010-09-09 Immunohealth International, Llc Method of analysis, detection and correction of food intolerance in humans
US20090253154A1 (en) 2008-04-02 2009-10-08 Immunosciences Lab., Inc. Blood and saliva test for detection of delayed food allergy and intolerance against modified foods
KR20090108968A (ko) 2008-04-14 2009-10-19 이연희 성인병 전문식당 서비스 시스템 및 그 운영방법
WO2010049726A1 (en) 2008-10-27 2010-05-06 The University Of Nottingham Protein extraction, protein microarray and uses thereof
GB0900623D0 (en) 2009-01-15 2009-02-25 Cardiff & Vale Nhs Trust A method for diagnosing food allergy
US7892763B2 (en) 2009-01-26 2011-02-22 Dodds W Jean Multi-stage nutrigenomic diagnostic food sensitivity testing in animals
US20130183692A1 (en) * 2009-01-26 2013-07-18 W. Jean Dodds Intolerance testing for ingredients in nutrients, flavorings and therapeutics
WO2010101255A1 (ja) * 2009-03-05 2010-09-10 味の素株式会社 クローン病診断試薬
DK2494356T3 (en) * 2009-10-26 2017-05-15 Genentech Inc ASSAYS FOR THE DETECTION OF ANTIBODIES SPECIFIC TO THERAPEUTIC ANTI-IGE ANTIBODIES AND THEIR USE OF ANAPHYLAXY
JP2011178679A (ja) * 2010-02-26 2011-09-15 Kitasato Institute 和漢生薬由来多糖体を有効成分とする免疫調節剤及び飲食品
US20110306898A1 (en) 2010-06-09 2011-12-15 Michael Stierstorfer IBS Related Testing and Treatment
US20110318717A1 (en) 2010-06-23 2011-12-29 Laurent Adamowicz Personalized Food Identification and Nutrition Guidance System
US9292565B2 (en) 2010-06-30 2016-03-22 International Business Machines Corporation Template-based recognition of food product information
US20120283953A1 (en) * 2011-05-06 2012-11-08 Boe Trond Hellem Line and edge detection and enhancement
US9053483B2 (en) 2011-09-30 2015-06-09 Microsoft Technology Licensing, Llc Personal audio/visual system providing allergy awareness
US20140322678A1 (en) 2013-04-24 2014-10-30 Kitchology Inc. Presentation of food information on a personal and selective dynamic basis and associated services
KR20130127145A (ko) 2012-05-14 2013-11-22 주식회사 푸른건강가족 복합 처방 서비스 시스템 및 방법
US10130665B2 (en) * 2012-05-18 2018-11-20 Genome Research Limited Method for identifying bacteria for bacteriotherapy
US10150982B2 (en) 2013-03-14 2018-12-11 Second Genome, Inc. Microbial ecology shift assay
WO2014182932A1 (en) 2013-05-08 2014-11-13 The Board Of Trustees Of The Leland Stanford Junior University Methods of testing for allergen sensitivity
US9212996B2 (en) 2013-08-05 2015-12-15 Tellspec, Inc. Analyzing and correlating spectra, identifying samples and their ingredients, and displaying related personalized information
DE102013014080A1 (de) 2013-08-27 2015-03-05 Marco Mühle Informationssystem für Multi-Allergiker
CA3145879C (en) 2014-11-14 2025-07-08 Biomerica, Inc. Compositions, devices, and methods of ibs sensitivity testing
KR102332418B1 (ko) * 2015-01-30 2021-11-26 사이렉스 래보라토리즈 엘엘씨 다수의 식품 항원들 및 c1q-식품 단백질 면역 복합체에 대한 igg 항체 및 iga 항체의 동시 특징분석
KR20180043790A (ko) 2015-07-22 2018-04-30 바이오메리카인코포레이티드 식품 민감도 시험에 근거하여 식품 권고를 제공하기 위한 시스템 및 방법
US20190056408A1 (en) 2015-09-09 2019-02-21 Biomerica, Inc. Compositions, devices, and methods of osteoarthritis sensitivity testing
CN108700575A (zh) 2015-12-21 2018-10-23 拜尔梅里科有限公司 偏头痛食物敏感测试的组合物、设备以及方法
EP3394623B1 (en) 2015-12-21 2024-08-21 Biomerica, Inc. Compositions, devices, and methods of psoriasis food sensitivity testing
WO2017156313A1 (en) 2016-03-09 2017-09-14 Biomerica, Inc. Compositions, devices, and methods of functional dyspepsia sensitivity testing
AU2017235312A1 (en) 2016-03-15 2018-10-04 Biomerica, Inc. Compositions, devices, and methods of fibromyalgia sensitivity testing
AU2017257278A1 (en) 2016-04-26 2018-12-06 Biomerica, Inc. Compositions, devices, and methods of Crohn's Disease sensitivity testing
MX2018013120A (es) 2016-04-26 2019-03-28 Biomerica Inc Composiciones, dispositivos y metodos de prueba de sensibilidad a la colitis ulcerosa.
EP3468458B1 (en) 2016-06-13 2024-09-11 Biomerica Inc. Compositions, devices, and methods of gastroesophageal reflux disease sensitivity testing
EP3497447B1 (en) 2016-07-08 2024-09-04 Biomerica, Inc. Compositions, devices, and methods of depression sensitivity testing
CA3085431A1 (en) 2016-12-15 2018-06-21 Biomerica, Inc. Compositions, devices, and methods of attention deficit disorder/attention deficit hyperactivity disorder (add/adhd) sensitivity testing

Also Published As

Publication number Publication date
JP7544405B2 (ja) 2024-09-03
CN113671173A (zh) 2021-11-19
US20210172960A1 (en) 2021-06-10
KR101887545B1 (ko) 2018-08-10
WO2016077808A1 (en) 2016-05-19
CA2967817C (en) 2022-03-15
EP3940380A1 (en) 2022-01-19
KR20210029830A (ko) 2021-03-16
CN115248311A (zh) 2022-10-28
HK1243178A1 (zh) 2018-07-06
MX2021009297A (es) 2021-09-08
MX385004B (es) 2025-03-14
JP2021051093A (ja) 2021-04-01
CN107110855A (zh) 2017-08-29
KR102224649B1 (ko) 2021-03-05
MX2017006228A (es) 2018-01-23
US20190242901A1 (en) 2019-08-08
US10788498B2 (en) 2020-09-29
CA3145879C (en) 2025-07-08
JP2019105652A (ja) 2019-06-27
JP2023041920A (ja) 2023-03-24
US10309970B2 (en) 2019-06-04
KR20220038183A (ko) 2022-03-25
AU2015346097A1 (en) 2017-04-27
CA3145879A1 (en) 2016-05-19
CA2967817A1 (en) 2016-05-19
AU2022201127A1 (en) 2022-03-10
KR20170054522A (ko) 2017-05-17
PE20171093A1 (es) 2017-08-07
SG10201912464QA (en) 2020-02-27
CN113671174A (zh) 2021-11-19
EP3218716A4 (en) 2018-07-18
AU2020233774A1 (en) 2020-10-15
JP6876338B2 (ja) 2021-05-26
US20230417758A1 (en) 2023-12-28
AU2020233774B2 (en) 2021-11-25
CO2017005773A2 (es) 2017-10-20
JP2017535791A (ja) 2017-11-30
US20170322223A1 (en) 2017-11-09
EP3218716A1 (en) 2017-09-20
JP6681907B2 (ja) 2020-04-15
BR112017010078A2 (pt) 2018-02-14
HK1244317A1 (zh) 2018-08-03
KR102375614B1 (ko) 2022-03-16
KR20180089574A (ko) 2018-08-08
SG11201705102QA (en) 2017-07-28
AU2018203500A1 (en) 2018-06-07

Similar Documents

Publication Publication Date Title
CO2017005773A2 (es) Composiciones, dispositivos, y métodos de pruebas de sensibilidad del ibs
MX2017008421A (es) Métodos terapéuticos, diagnósticos y pronósticos para el cáncer de vejiga.
BR112017007965A2 (pt) método implantado por computador para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; aparelho para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; meio de armazenamento não transitório; programa de computador; kits para medir níveis de expressão de três ou mais genes-alvo da via de sinalização celular de tgf-b em uma amostra de um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; e uso do kit
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
MX2017003790A (es) Detección de secuencias diana por percepción de nanoporos de sondas sintéticas.
BR112016030798A8 (pt) composição de marcação fluorescente, métodos para determinar se um local foi limpo e para avaliar a limpeza de uma superfície, e, kits para determinar se uma superfície foi limpa e para avaliar a limpeza de uma superfície
MX2021006791A (es) Metodos y composiciones para detectar proteinas mal plegadas.
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
MX2018005448A (es) Metodos para la deteccion de apolipoproteinas.
WO2015164747A8 (en) Methods for diagnosing celiac disease using circulating cytokines/chemokines
UY36223A (es) Dispositivos para ensayos, métodos para realizar ensayos, kits para ensayos y método para fabricar dispositivos para ensayos
MX2015013436A (es) Metodo de determinacion del sexo de un embrion en un huevo.
MX2016016742A (es) Ceramidas y su uso en el diagnostico de enfermedad cardiovascular (ecv).
EP4700372A3 (en) Luminescence measurements in diamond
MX2018002947A (es) Composiciones, dispositivos, y métodos de pruebas de sensibilidad a la osteoartritis.
MX2018007567A (es) Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos de personas con psoriasis.
MX2023005293A (es) Composiciones, dispositivos y metodos de prueba de sensibilidad a la depresion.
MX2018010856A (es) Composiciones, dispositivos y metodos de pruebas de sensibilidad de dispepsia funcional.
MX2016012278A (es) Deteccion temprana de preeclampsia.
MX2018011166A (es) Composiciones, dispositivos y metodos de prueba de sensibilidad de fibromialgia.
MX2018013118A (es) Composiciones, dispositivos y métodos de pruebas de sensibilidad a la enfermedad de crohn.
MX2018015334A (es) Composiciones, dispositivos y métodos de prueba de sensibilidad a los alimentos a la enfermedad de reflujo gastroesofageal.
MX2018013120A (es) Composiciones, dispositivos y metodos de prueba de sensibilidad a la colitis ulcerosa.
CL2016003162A1 (es) Predicción de la capacidad del salmón atlántico para utilizar el pigmento dietético basado en la determinación de los polimorfismos.
AR102355A1 (es) Determinación de analitos en la matriz de muestra por extracción de solvente